Association between Antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: A cohort study using the Health Improvement Network

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Meeraus, Wilhelmine Hadler ^a,b   Petersen, Irene ^b   Gilbert, Ruth ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Farr Institute of Health Informatics Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MACROLIDE; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CEREBRAL PALSY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CLASSIFICATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; TERM BIRTH; YOUNG ADULT; FOLLOW UP; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURITY; PRENATAL EXPOSURE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CEREBRAL PALSY; COHORT STUDIES; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MACROLIDES; MIDDLE AGED; PENICILLINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84930786789     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122034     Document Type: Article

References (67)

1. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004; 191: 398-407. PMID: 15343213
2. Bakker MK, Jentink J, Vroom F, van den Berg PB, De Walle HEK, De Jong-Van Den Berg LTW, et al. Maternal medicine: Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006; 113: 559-568. PMID: 16637899
3. Crespin S, Bourrel R, Hurault-Delarue C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Drug Prescribing Before and During Pregnancy in South West France. Drug Saf. 2011; 34: 595-604. doi: 10.2165/11589170-000000000-00000 PMID: 21663335
4. Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription Drug Use in Pregnancy: A Retrospective, Population-Based Study in British Columbia, Canada (2001-2006). Clin Ther. 2012; 34: 239-249. doi: 10.1016/j.clinthera.2011.11.025 PMID: 22169049
5. Stokholm J, Schjorring S, Pedersen L, Bischoff AL, Folsgaard N, Carson CG, et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS ONE. 2013; 8: e82932. doi: 10.1371/journal.pone.0082932 PMID: 24340068
6. Bjorn AM, Norgaard M, Hundborg HH, Nohr EA, Ehrenstein V. Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark. Clin Epidemiol. 2011; 3: 149-156. doi: 10.2147/CLEP.S17747 PMID: 21607016
7. Koren G, Bologa M, Long D, Feldman Y, Shear NH. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol. 1989; 160: 1190-1194. PMID: 2729394
8. Koren G, Pastuszak A, Ito S. Drug therapy - Drugs in pregnancy. N Engl J Med. 1998; 338: 1128-1137. PMID: 9545362
9. Vazquez JC, Villar J. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database of Systematic Reviews: The Cochrane Library. 2003 Issue 4. Chichester (UK): John Wiley & Sons, Ltd. PMID: 12918010
10. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews: The Cochrane Library. 2007 Issue 2. Chichester (UK): John Wiley & Sons, Ltd. PMID: 17253489
11. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database of Systematic Reviews: The Cochrane Library. 2013, Issue 12. Chicester (UK): John Wiley & Sons, Ltd.
12. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008; 372: 1319-1327. doi: 10.1016/S0140-6736(08)61203-9 PMID: 18804276
13. Jones D. Supplementary materials for Lancet ORACLE Childrens Study papers 2008 (SPL Table W3.6) [Table]. 2008. Available: www2.le.ac.uk/Members/drj/supplementary-materials-for-lancet-sept-08-paper. Accessed 2014 Sep 21.
14. Jones D. Supplementary materials for Lancet ORACLE Childrens Study papers 2008 (SPL Table W3.3) [Table]. 2008. Available: www2.le.ac.uk/Members/drj/supplementary-materials-for-lancet-sept-08-paper. Accessed 2014 Sep 21.
15. Marlow N, Pike K, Bower E, Brocklehurst P, Jones D, Kenyon S, et al. Characteristics of children with cerebral palsy in the ORACLE children study. Dev Med Child Neurol. 2012; 54: 640-646. doi: 10.1111/j.1469-8749.2012.04274.x PMID: 22458348
16. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am J Epidemiol. 2002; 155: 176-184. PMID: 11790682
17. Royal College of Obstetricians and Gynaecologists. Scientific Impact Paper No. 33: Preterm labour, antibiotics & cerebral palsy. London, UK: RCOG; 2013.
18. Charlton RA, Neville AJ, Jordan S, Pierini A, Damase-Michel C, Klungsoyr K, et al. Healthcare databases in Europe for studying medicine use and safety during pregnancy. Pharmacoepidemiol Drug Saf. 2014; 6: 586-594. doi: 10.1002/pds.3613 PMID: 24664855
19. CSD, EPIC. THIN Data Guide for Researchers. Version 2.0. 2010.
20. Garcia Rodriguez LA, Perez GS. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998; 45: 419-425. PMID: 9643612
21. Joint Formulary Committee. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain. 2009.
22. Chisholm J. The Read clinical classification. BMJ. 1990; 300: 1092. PMID: 2344534
23. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004; 12: 171-177. PMID: 15606990
24. Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011; 19: 251-255. PMID: 22828580
25. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007; 16: 393-401. PMID: 17066486
26. Jick H, Terris BZ, Derby LE, Jick S. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf. 1992; 1: 347-349.
27. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010; 69: 4-14. doi: 10.1111/j.1365-2125.2009.03537.x PMID: 20078607
28. Colbourn TE, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analyses. Health Technol Assess. 2007; 11(29). PMID: 17651659
29. Meeraus WH, Petersen I, Chin RF, Knott F, Gilbert R. Childhood epilepsy recorded in primary care in the UK. Arch Dis Child. 2013; 98: 195-202. doi: 10.1136/archdischild-2012-302237 PMID: 23343522
30. Meeraus WH, Petersen I, Gilbert R. Chronic medical conditions influence prescribing of antibiotics in pregnancy. Pharmacoepidem Drug Saf. 2011; 20: S54.
31. Morris R, Carstairs V. Which deprivation? A comparison of selected deprivation indexes. J Public Health (Oxf). 1991; 13: 318-326.
32. Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy - A meta-analysis. JAMA. 2000; 284: 1417-1424. PMID: 10989405
33. Sun Y, Vestergaard M, Christensen J, Nahmias AJ, Olsen J. Prenatal exposure to maternal infections and epilepsy in childhood: A population-based cohort study. Pediatrics. 2008; 121: E1100-E1107. doi: 10.1542/peds.2007-2316 PMID: 18450853
34. Williamson E, Morley R, Lucas A, Carpenter J. Propensity scores: From nave enthusiasm to intuitive understanding. Stat Methods Med Res. 2011; 21: 273-293. doi: 10.1177/0962280210394483 PMID: 21262780
35. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999; 319: 1492-1495. PMID: 10582940
36. Norgaard M, Ehrenstein V, Nielsen RB, Bakketeig LS, Sorensen HT. Maternal use of antibiotics, hospitalisation for infection during pregnancy, and risk of childhood epilepsy: A population-based cohort study. PLoS ONE. 2012; 7: e30850. doi: 10.1371/journal.pone.0030850 PMID: 22295115
37. Miller JE, Pedersen LH, Streja E, Bech BH, Yeargin-Allsopp M, Van Naarden BK, et al. Maternal infections during pregnancy and cerebral palsy: a population-based cohort study. Paediatr Perinat Epidemiol. 2013; 27: 542-552. doi: 10.1111/ppe.12082 PMID: 24117888
38. Lieberman D, Lieberman D, Korsonsky I, Ben-Yaakov M, Lazarovich Z, Friedman MG, et al. A comparative study of the etiology of adult upper and lower respiratory tract infections in the community. Diagn Microbiol Infect Dis. 2002; 42: 21-28. PMID: 11821167
39. Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int. 2012;796590.
40. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA (USA): Lippincott Williams & Wilkins; 2008.
41. Tin W, Fritz S, Wariyar U, Hey E. Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty. Arch Dis Child Fetal Neonatal Ed. 1998; 79: F83-F87. PMID: 9828731
42. Langley JM, Halperin SA, Boucher FD, Smith B, Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics. 2004; 114: e96-e101. PMID: 15231980
43. Devasia RA, Jones TF, Collier B, Schaffner W. Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak. Am J Med Sci. 2009; 337: 176-178. PMID: 19301451
44. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, et al. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Clin Ther. 2008; 30: 358-371. doi: 10.1016/j.clinthera.2008.01.023 PMID: 18343274
45. Ostrea EM Jr, Mantaring JB III, Silvestre MA. Drugs that affect the fetus and newborn infant via the placenta or breast milk. Pediatr Clin North Am. 2004; 51: 539-579. PMID: 15157585
46. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG. 2000; 107: 770-775. PMID: 10847234
47. Petersen I, Gilbert R, Evans S, Ridolfi A, Nazareth I. Oral antibiotic prescribing during pregnancy in primary care: UK population-based study. J Antimicrob Chemother. 2010; 65: 2238-2246. doi: 10.1093/jac/dkq307 PMID: 20716554
48. Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, et al. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. BMJ. 2013; 346: f1235. doi: 10.1136/bmj.f1235 PMID: 23525864
49. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. New England Journal of Medicine. 2012; 366: 1881-1890. doi: 10.1056/NEJMoa1003833 PMID: 22591294
50. Svanstrom H, Pasternak B, Hviid A. Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study. BMJ. 2014; 349: g4930. doi: 10.1136/bmj.g4930 PMID: 25139799
51. Guo D, Cai Y, Chai D, Liang B, Bai N, Wang R. The cardiotoxicity of macrolides: a systematic review. Pharmazie. 2010; 65: 631-640. PMID: 21038838
52. Andersen JT, Petersen M, Jimenez-Solem E, Broedbaek K, Andersen NL, Torp-Pedersen C, et al. Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS ONE. 2013; 8: e53327. doi: 10.1371/journal.pone.0053327 PMID: 23301061
53. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009; 163: 978-985. doi: 10.1001/archpediatrics.2009.188 PMID: 19884587
54. Kallen BA, Otterblad OP, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol. 2005; 20: 209-214. PMID: 15907655
55. Kallen B, Danielsson BR. Fetal safety of erythromycin: An update of Swedish data. Eur J Clin Pharmacol. 2014; 70: 355-360. doi: 10.1007/s00228-013-1624-3 PMID: 24352632
56. Lin KJ, Mitchell AA, Yau WP, Louik C, Hernandez Diaz S. Safety of macrolides during pregnancy. Am J Obstet Gynecol. 2013; 208:221.e1-e8. doi: 10.1016/j.ajog.2012.12.023 PMID: 23254249
57. Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, et al. Fetal safety of macrolides. Antimicrob Agents Chemother. 2013; 57: 3307-3311. doi: 10.1128/AAC.01691-12 PMID: 23650169
58. Bril F, Gonzalez CD, Di GG. Antimicrobial agents-associated with QT interval prolongation. Curr Drug Saf. 2010; 5: 85-92. PMID: 20210724
59. Danielsson BR, Skold AC, Azarbayjani F. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage. Curr Pharm Des. 2001; 7: 787-802. PMID: 11375779
60. Danielsson BR, Danielsson C, Nilsson MF. Embryonic cardiac arrhythmia and generation of reactive oxygen species: Common teratogenic mechanism for IKr blocking drugs. Reprod Toxicol. 2007; 24: 42-56. PMID: 17570632
61. Webster WS, Abela D. The effect of hypoxia in development. Birth Defects Res C Embryo Today. 2007; 81: 215-228. PMID: 17963271
62. Kallen BAJ, Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reproductive Toxicology. 2006; 21: 221-222. PMID: 16406480
63. Hutter D, Kingdom J, Jaeggi E. Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review. Int J Pediatr. 2010: 401323.
64. Himmelmann K, Ahlin K, Jacobsson B, Cans C, Thorsen P. Risk factors for cerebral palsy in children born at term. Acta Obstet Gynecol Scand. 2011; 90: 1070-1081. doi: 10.1111/j.1600-0412.2011.01217.x PMID: 21682697
65. Vannucci RC. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr Res. 1990; 27: 317-326. PMID: 1971436
66. Kendall G, Peebles D. Acute fetal hypoxia: the modulating effect of infection. Early Hum Dev. 2005; 81: 27-34. PMID: 15707712
67. Macnab A. The etiology and evolution of fetal brain injury. In: Gonzalez-Quevedo A, editors. Brain damage - Bridging between basic research and clinics. Rijeka, Croatia: InTech Europe. 2012. pp. 1-38.